Reviva Pharmaceuticals Holdings Inc (RVPH)
1.87
-0.13
(-6.50%)
USD |
NASDAQ |
Jan 08, 16:00
1.86
-0.01
(-0.53%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings SG&A Expense (Quarterly): 1.604M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Pfizer Inc | 3.244B |
| Verastem Inc | 12.28M |
| AbbVie Inc | 4.205B |
| Lipocine Inc | 1.045M |
| Applied Therapeutics Inc | 15.04M |